Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Cognition and eye movements: assessment of cerebral dysfunction.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
Is metabolic flexibility altered in multiple sclerosis patients?
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
What is microglia neurotoxicity (Not)?
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus.
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
The HLA region in multiple sclerosis.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Pediatric Multiple Sclerosis-A Challenging Demyelinating Disease: Case Report and Brief Review of the Literature.
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Pages